Biomind Labs Inc.
BMNDF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$19.41M
Close$
$-0.01
103.8% downside
Current Fair Value
103.8% downsideOvervalued by 103.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $19.41 Million |
|---|---|
| Enterprise Value | $20.24 Million |
| Earnings per Share | $-0.01 |
| Beta | 7.28 |
| Outstanding Shares | 77,571,772 |
Return
| Return on Equity | 76.75% |
|---|---|
| Return on Assets | -4170814.29% |
| Return on Invested Capital | 72.47% |
Valuation & Multiples
| P/E Ratio | -13.31 |
|---|---|
| PEG | -2.74 |
| Price to Sales | - |
| Price to Book Ratio | -0.25 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -14.68 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | -0.44 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Biomind Labs Inc.
5 employees
CEO: Alejandro Antalich
Biomind Labs Inc. operates as a biotechnology firm dedicated to advancing innovative pharmaceutical therapies and sophisticated nanotech drug delivery mechanisms, primarily addressing a range of psychiatric and neurological disorders. Am...